Cite
HARVARD Citation
Sekimizu, M. et al. (n.d.). Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib. Leukemia & lymphoma. 55 (7), pp. 1652-1653. [Online].